NHLBI DNA Re-sequencing and Genotyping Program -- Genotyping Center

NHLBI DNA 重测序和基因分型项目 -- 基因分型中心

• 批准号: 7937134
• 负责人: ALAN SCOTT
• 金额: $ 96.86万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-30 至 2010-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7937134
• 关键词: NHLBI; DNA; Re; sequencing; Genotyping

The overall objective of the National Heart, Lung, and Blood Institute (NHLBI) DNA Re-sequencing and Genotyping (RS & G) Program is to obtain eliable, rapid, and cost-efficient DNA re-sequencing and genotyping of candidate genomic regions potentially important in the disease pathways of heart, lung, blood, and sleep disorders. This re-sequencing and genotyping information will assist ongoing investigations of the genetic components involved in the cause, variable outcome, and progression of heart, lung, blood, and sleep diseases and disorders.

国家心脏，肺和血液研究所（NHLBI）DNA重测序和基因分型（RS & G）计划的总体目标是获得可靠，快速和具有成本效益的候选基因组区域的DNA重测序和基因分型，这些区域在心脏，肺，血液和睡眠障碍的疾病途径中可能很重要。这种重新测序和基因分型信息将有助于正在进行的调查的原因，变量的结果，心脏，肺，血液和睡眠疾病和障碍的进展所涉及的遗传成分。